Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-29 @ 10:07 PM
Study NCT ID:
NCT00810303
Status:
COMPLETED
Last Update Posted:
2010-10-11
First Post:
2008-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Sponsor:
University Medicine Greifswald
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Efavirenz - 2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Prof. Dr. W. Siegmund, MD
Old Organization:
Organization: Department of Clinical Pharmacology